Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000276:immunology / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D003110:Colonic Neoplasms / Q000276:immunology / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive; D007370:Interferon Type I / Q000494:pharmacology; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy; D051379:Mice; D008819:Mice, Nude; D009369:Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000175:diagnosis
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D007370:Interferon Type I